Biosimilar monoclonal antibodies for cancer treatment

Página do item simplificado
dc.contributor.authorGalvão, Taís F
dc.contributor.authorLivinalli, Annemeri
dc.contributor.authorLopes, Luciane C
dc.contributor.authorZimmermann, Ivan R
dc.contributor.authorSilva, Marcus T
dc.date.accessioned2024-11-11T18:30:18Z
dc.date.available2024-11-11T18:30:18Z
dc.date.issued2020
dc.description.abstractThis is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the eIicacy, eIectiveness, and safety of biosimilar monoclonal antibodies fortreating cancer, when compared to their originator biologic.
dc.identifier.citationGalvão TF, Livinalli a, Lopes LC, Zimmermann IR, Silva MT. Biossimilar monoclonal antibodies for câncer treatment. Cochrane Database of Systematic Reviews 2020, Issue 2. Art. No.: CD0113539. DOI: 10.1002/14651858.
dc.identifier.otherDOI: 10.1002/14651858.CD013539
dc.identifier.urihttps://dspace.inc.saude.gov.br/handle/123456789/588
dc.language.isoen
dc.publisherCochrane Database of Systematic Reviews
dc.titleBiosimilar monoclonal antibodies for cancer treatment
dc.typeArticle
Arquivos
Original bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.alt
Nome:
Galvão TF et al_Cochrane Lib .pdf
Tamanho:
257.72 KB
Formato:
Adobe Portable Document Format
Descrição:
Baixar
License bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.placeholder
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed to upon submission
Descrição:
Baixar
Coleções
Produção Docente